Moreover, a study on oxaliplatin resistance regulation in colon cancer also revealed that linc00152 is involved in the linc00152/miR-193a-3p/erb-b2 receptor tyrosine kinase 4 (ERBB4) ceRNA signaling axis [33]. The gene discussed is ERBB4; the disease is malignant colon neoplasm.